{"id":59424,"date":"2025-01-15T15:58:39","date_gmt":"2025-01-15T14:58:39","guid":{"rendered":"https:\/\/mf.ag\/?p=59424"},"modified":"2025-01-20T09:05:17","modified_gmt":"2025-01-20T08:05:17","slug":"cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company","status":"publish","type":"post","link":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/","title":{"rendered":"Cross-Border Case Study Austria \u2013 France: Supporting the French subsidiary of a Swiss pharmaceutical company"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\" id=\"h-the-assignment\"><a href=\"https:\/\/www.linkedin.com\/company\/valtusalliance\/\"><\/a>The Assignment<\/h3>\n\n\n\n<p id=\"ember209\">An<a href=\"https:\/\/mf.ag\/en\/interim-ceo\/\"> Executive Interim CEO<\/a> was needed for a 6 month assignment at a company within the pharmaceutical industry, with placement in France.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ember211\">Outcome<\/h3>\n\n\n\n<p id=\"ember212\">Stabilization of the company\u2019s core aspects.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ember214\">Overwiew<\/h3>\n\n\n\n<p id=\"ember215\">Due to persisitent annual losses, the French subsidiary of a Swiss pharmaceutical company was facing significant difficulties. An Executive Interim CEO stepped in to increase revenue and profit margin within French entity.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/media.licdn.com\/dms\/image\/v2\/D4D12AQH8QmKPrticOg\/article-inline_image-shrink_1500_2232\/article-inline_image-shrink_1500_2232\/0\/1736259723668?e=1742428800&amp;v=beta&amp;t=uMZfzxyY1Z0nZ5FjKYs5N8WsI4snKjwii0nWLAvTr7Q\" alt=\"\"\/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ember218\">Our Approach:<\/h3>\n\n\n\n<p id=\"ember219\">Management Factory || Valtus in Austria outlined the client&#8217;s requirements and swiftly connected with <a href=\"https:\/\/www.linkedin.com\/company\/valtusfrance\/\" target=\"_blank\" rel=\"noreferrer noopener\">Valtus France &#8211; Shaping your success, worldwide<\/a> in France, who selected a suitable Executive Interim Manager.<\/p>\n\n\n\n<p id=\"ember220\"><em>&#8220;In Austria, we serve clients across the DACH region. When the Swiss pharmaceutical company reached out with concerns about its French susidiary, I was pleased to refer them to my French colleague.\u201d<\/em><\/p>\n\n\n\n<p id=\"ember221\">&#8211; <a href=\"https:\/\/www.linkedin.com\/in\/thomas-tschol-a95227\/\" target=\"_blank\" rel=\"noreferrer noopener\">Thomas Tschol<\/a>, Partner Austria<\/p>\n\n\n\n<figure class=\"wp-block-image is-resized\"><img decoding=\"async\" src=\"https:\/\/media.licdn.com\/dms\/image\/v2\/D4D12AQGlJVZlx5l6Ww\/article-inline_image-shrink_1000_1488\/article-inline_image-shrink_1000_1488\/0\/1736259190565?e=1742428800&amp;v=beta&amp;t=Peh_i3PayXWD7v7Rbh9mV681kw90XEmnv4wJUy31hLc\" alt=\"\" style=\"width:400px\"\/><figcaption class=\"wp-element-caption\"><em>Thomas Tschol<\/em><\/figcaption><\/figure>\n\n\n\n<p id=\"ember224\"><em>\u201cAlthough a French-speaking executive interim CEO was required, I ensured the selected professional was experienced in multicultural settings and could build trust with the Swiss shareholder.\u201d<\/em><\/p>\n\n\n\n<p id=\"ember225\"><a href=\"https:\/\/www.linkedin.com\/in\/emmanuelfretti\/\" target=\"_blank\" rel=\"noreferrer noopener\">Emmanuel Fretti<\/a>, Partner France<\/p>\n\n\n\n<figure class=\"wp-block-image is-resized\"><img decoding=\"async\" src=\"https:\/\/media.licdn.com\/dms\/image\/v2\/D4D12AQFV5uRto6Xk1w\/article-inline_image-shrink_1000_1488\/article-inline_image-shrink_1000_1488\/0\/1736259418135?e=1742428800&amp;v=beta&amp;t=mLd1dyzqb5sypU7A8vnnoyj8RKhD9vle8jTOOpAWw5s\" alt=\"\" style=\"width:400px\"\/><figcaption class=\"wp-element-caption\"><em>Emmanuel Fretti<\/em><\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ember229\">Challenges:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Enhance efficiency and improve pofitability by rethinking both the business model and the related commercial organization<\/li>\n\n\n\n<li>Improve reliability of operational processes and financial records<\/li>\n\n\n\n<li>Provide reassurance to the Swiss shareholder<\/li>\n\n\n\n<li>Stabilize and strenghthen teams<\/li>\n<\/ul>\n\n\n\n<p id=\"ember238\"><em>\u201cI have worked extensively in a multicultural environment, which allows me to understand how to manage the expectations of a non French stakeholder. My role also involved providing cultural perspectives on the challenges faced in France to the Swiss management and vice versa.\u201d<\/em><\/p>\n\n\n\n<p id=\"ember239\"><a href=\"https:\/\/www.linkedin.com\/in\/marc-thibiant-b21998\/\" target=\"_blank\" rel=\"noreferrer noopener\">Marc THIBIANT<\/a>, Executive Interim CEO with 15years of experience in General Management.<br><\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"225\" height=\"225\" src=\"https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/thumbnail_image006.webp\" alt=\"\" class=\"wp-image-59471\" style=\"width:400px\" srcset=\"https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/thumbnail_image006.webp 225w, https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/thumbnail_image006-24x24.webp 24w, https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/thumbnail_image006-48x48.webp 48w, https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/thumbnail_image006-96x96.webp 96w, https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/thumbnail_image006-150x150.webp 150w\" sizes=\"auto, (max-width: 225px) 100vw, 225px\" \/><figcaption class=\"wp-element-caption\">Marc Thibiant<\/figcaption><\/figure>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Assignment An Executive Interim CEO was needed for a 6 month assignment at a company within the pharmaceutical industry, with placement in France. Outcome Stabilization of the company\u2019s core aspects. Overwiew Due to persisitent annual losses, the French subsidiary of a Swiss pharmaceutical company was facing significant difficulties. An Executive Interim CEO stepped in [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":59432,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2788,3268],"tags":[3168,3124,3516,3624],"class_list":["post-59424","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-artikel","tag-ceo","tag-cross-border-2","tag-executive-interim-management-en","tag-valtus-en"],"featured_image_urls_v2":{"full":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079.png",1920,1080,false],"thumbnail":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079-250x250.png",250,250,true],"medium":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079-300x169.png",300,169,true],"medium_large":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079-768x432.png",768,432,true],"large":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079-1024x576.png",1024,576,true],"1536x1536":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079-1536x864.png",1536,864,true],"2048x2048":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079.png",1920,1080,false],"gform-image-choice-sm":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079.png",300,169,false],"gform-image-choice-md":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079.png",400,225,false],"gform-image-choice-lg":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079.png",600,338,false],"profile_24":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079-24x24.png",24,24,true],"profile_48":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079-48x48.png",48,48,true],"profile_96":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079-96x96.png",96,96,true],"profile_150":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079-150x150.png",150,150,true],"profile_300":["https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079-300x300.png",300,300,true]},"post_excerpt_stackable_v2":"<p>The Assignment An Executive Interim CEO was needed for a 6 month assignment at a company within the pharmaceutical industry, with placement in France. Outcome Stabilization of the company\u2019s core aspects. Overwiew Due to persisitent annual losses, the French subsidiary of a Swiss pharmaceutical company was facing significant difficulties. An Executive Interim CEO stepped in to increase revenue and profit margin within French entity. Our Approach: Management Factory || Valtus in Austria outlined the client&#8217;s requirements and swiftly connected with Valtus France &#8211; Shaping your success, worldwide in France, who selected a suitable Executive Interim Manager. &#8220;In Austria, we serve&hellip;<\/p>\n","category_list_v2":"<a href=\"https:\/\/mf.ag\/en\/category\/articles\/\" rel=\"category tag\">Articles<\/a>, <a href=\"https:\/\/mf.ag\/de\/category\/artikel\/\" rel=\"category tag\">Artikel<\/a>","author_info_v2":{"name":"VALTUS Management Factory","url":"https:\/\/mf.ag\/en\/author\/managementfactory\/"},"comments_num_v2":"0 comments","yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Cross-Border Case Study Austria \u2013 France: Supporting the French subsidiary of a Swiss pharmaceutical company &#187; Management Factory<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cross-Border Case Study Austria \u2013 France: Supporting the French subsidiary of a Swiss pharmaceutical company\" \/>\n<meta property=\"og:description\" content=\"The Assignment An Executive Interim CEO was needed for a 6 month assignment at a company within the pharmaceutical industry, with placement in France. Outcome Stabilization of the company\u2019s core aspects. Overwiew Due to persisitent annual losses, the French subsidiary of a Swiss pharmaceutical company was facing significant difficulties. An Executive Interim CEO stepped in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/\" \/>\n<meta property=\"og:site_name\" content=\"Management Factory\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-15T14:58:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-20T08:05:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"VALTUS Management Factory\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"VALTUS Management Factory\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/\"},\"author\":{\"name\":\"VALTUS Management Factory\",\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/#\\\/schema\\\/person\\\/1b1a766599b72b46cce17aecef0a2280\"},\"headline\":\"Cross-Border Case Study Austria \u2013 France: Supporting the French subsidiary of a Swiss pharmaceutical company\",\"datePublished\":\"2025-01-15T14:58:39+00:00\",\"dateModified\":\"2025-01-20T08:05:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/\"},\"wordCount\":272,\"publisher\":{\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mf.ag\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Posts-fuer-Website-2025-01-15T160553.079.png\",\"keywords\":[\"CEO\",\"Cross-Border\",\"Executive Interim Management\",\"Valtus\"],\"articleSection\":[\"Articles\",\"Artikel\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/\",\"url\":\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/\",\"name\":\"Cross-Border Case Study Austria \u2013 France: Supporting the French subsidiary of a Swiss pharmaceutical company &#187; Management Factory\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mf.ag\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Posts-fuer-Website-2025-01-15T160553.079.png\",\"datePublished\":\"2025-01-15T14:58:39+00:00\",\"dateModified\":\"2025-01-20T08:05:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mf.ag\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Posts-fuer-Website-2025-01-15T160553.079.png\",\"contentUrl\":\"https:\\\/\\\/mf.ag\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Posts-fuer-Website-2025-01-15T160553.079.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/articles\\\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mf.ag\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cross-Border Case Study Austria \u2013 France: Supporting the French subsidiary of a Swiss pharmaceutical company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/mf.ag\\\/en\\\/\",\"name\":\"Management Factory\",\"description\":\"Mit Executive Interim Management und Financial Advisory das Gesch\u00e4ft voranbringen\",\"publisher\":{\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mf.ag\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/#organization\",\"name\":\"Management Factory\",\"url\":\"https:\\\/\\\/mf.ag\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Management Factory\"},\"image\":{\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mf.ag\\\/en\\\/#\\\/schema\\\/person\\\/1b1a766599b72b46cce17aecef0a2280\",\"name\":\"VALTUS Management Factory\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2e920f1a23e073db8a64336053afe342ca0876d1bcaeba2cb8be10b4812cf9de?s=96&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2e920f1a23e073db8a64336053afe342ca0876d1bcaeba2cb8be10b4812cf9de?s=96&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2e920f1a23e073db8a64336053afe342ca0876d1bcaeba2cb8be10b4812cf9de?s=96&r=g\",\"caption\":\"VALTUS Management Factory\"},\"description\":\"VALTUS Management Factory ist ein f\u00fchrendes Unternehmen f\u00fcr Executive Interim Management, Financial Advisory und Restrukturierung in \u00d6sterreich und unterst\u00fctzt Organisationen in Transformations-, Wachstums- und Krisensituationen mit erfahrenen F\u00fchrungspers\u00f6nlichkeiten. Als Teil der internationalen Valtus Group verbindet das Unternehmen operative Umsetzungskompetenz mit globaler Management- und Restrukturierungsexpertise.\",\"url\":\"https:\\\/\\\/mf.ag\\\/en\\\/author\\\/managementfactory\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cross-Border Case Study Austria \u2013 France: Supporting the French subsidiary of a Swiss pharmaceutical company &#187; Management Factory","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/","og_locale":"en_US","og_type":"article","og_title":"Cross-Border Case Study Austria \u2013 France: Supporting the French subsidiary of a Swiss pharmaceutical company","og_description":"The Assignment An Executive Interim CEO was needed for a 6 month assignment at a company within the pharmaceutical industry, with placement in France. Outcome Stabilization of the company\u2019s core aspects. Overwiew Due to persisitent annual losses, the French subsidiary of a Swiss pharmaceutical company was facing significant difficulties. An Executive Interim CEO stepped in [&hellip;]","og_url":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/","og_site_name":"Management Factory","article_published_time":"2025-01-15T14:58:39+00:00","article_modified_time":"2025-01-20T08:05:17+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079.png","type":"image\/png"}],"author":"VALTUS Management Factory","twitter_card":"summary_large_image","twitter_misc":{"Written by":"VALTUS Management Factory","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/#article","isPartOf":{"@id":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/"},"author":{"name":"VALTUS Management Factory","@id":"https:\/\/mf.ag\/en\/#\/schema\/person\/1b1a766599b72b46cce17aecef0a2280"},"headline":"Cross-Border Case Study Austria \u2013 France: Supporting the French subsidiary of a Swiss pharmaceutical company","datePublished":"2025-01-15T14:58:39+00:00","dateModified":"2025-01-20T08:05:17+00:00","mainEntityOfPage":{"@id":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/"},"wordCount":272,"publisher":{"@id":"https:\/\/mf.ag\/en\/#organization"},"image":{"@id":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/#primaryimage"},"thumbnailUrl":"https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079.png","keywords":["CEO","Cross-Border","Executive Interim Management","Valtus"],"articleSection":["Articles","Artikel"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/","url":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/","name":"Cross-Border Case Study Austria \u2013 France: Supporting the French subsidiary of a Swiss pharmaceutical company &#187; Management Factory","isPartOf":{"@id":"https:\/\/mf.ag\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/#primaryimage"},"image":{"@id":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/#primaryimage"},"thumbnailUrl":"https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079.png","datePublished":"2025-01-15T14:58:39+00:00","dateModified":"2025-01-20T08:05:17+00:00","breadcrumb":{"@id":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/#primaryimage","url":"https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079.png","contentUrl":"https:\/\/mf.ag\/wp-content\/uploads\/2025\/01\/Posts-fuer-Website-2025-01-15T160553.079.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/mf.ag\/en\/articles\/cross-border-case-study-austria-france-supporting-the-french-subsidiary-of-a-swiss-pharmaceutical-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mf.ag\/en\/"},{"@type":"ListItem","position":2,"name":"Cross-Border Case Study Austria \u2013 France: Supporting the French subsidiary of a Swiss pharmaceutical company"}]},{"@type":"WebSite","@id":"https:\/\/mf.ag\/en\/#website","url":"https:\/\/mf.ag\/en\/","name":"Management Factory","description":"Mit Executive Interim Management und Financial Advisory das Gesch\u00e4ft voranbringen","publisher":{"@id":"https:\/\/mf.ag\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mf.ag\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mf.ag\/en\/#organization","name":"Management Factory","url":"https:\/\/mf.ag\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mf.ag\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Management Factory"},"image":{"@id":"https:\/\/mf.ag\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/mf.ag\/en\/#\/schema\/person\/1b1a766599b72b46cce17aecef0a2280","name":"VALTUS Management Factory","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/2e920f1a23e073db8a64336053afe342ca0876d1bcaeba2cb8be10b4812cf9de?s=96&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2e920f1a23e073db8a64336053afe342ca0876d1bcaeba2cb8be10b4812cf9de?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2e920f1a23e073db8a64336053afe342ca0876d1bcaeba2cb8be10b4812cf9de?s=96&r=g","caption":"VALTUS Management Factory"},"description":"VALTUS Management Factory ist ein f\u00fchrendes Unternehmen f\u00fcr Executive Interim Management, Financial Advisory und Restrukturierung in \u00d6sterreich und unterst\u00fctzt Organisationen in Transformations-, Wachstums- und Krisensituationen mit erfahrenen F\u00fchrungspers\u00f6nlichkeiten. Als Teil der internationalen Valtus Group verbindet das Unternehmen operative Umsetzungskompetenz mit globaler Management- und Restrukturierungsexpertise.","url":"https:\/\/mf.ag\/en\/author\/managementfactory\/"}]}},"_links":{"self":[{"href":"https:\/\/mf.ag\/en\/wp-json\/wp\/v2\/posts\/59424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mf.ag\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mf.ag\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mf.ag\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/mf.ag\/en\/wp-json\/wp\/v2\/comments?post=59424"}],"version-history":[{"count":5,"href":"https:\/\/mf.ag\/en\/wp-json\/wp\/v2\/posts\/59424\/revisions"}],"predecessor-version":[{"id":59474,"href":"https:\/\/mf.ag\/en\/wp-json\/wp\/v2\/posts\/59424\/revisions\/59474"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mf.ag\/en\/wp-json\/wp\/v2\/media\/59432"}],"wp:attachment":[{"href":"https:\/\/mf.ag\/en\/wp-json\/wp\/v2\/media?parent=59424"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mf.ag\/en\/wp-json\/wp\/v2\/categories?post=59424"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mf.ag\/en\/wp-json\/wp\/v2\/tags?post=59424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}